 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Eris Lifesciences Ltd has approved the allotment of 2161 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per share has been made on 20.11.2018, pursuant to exercise of options under its ESOP-2017 Scheme.
The paid up share capital of the Company has accordingly been increased from Rs. 13,75,15,461/- (13,75,15,461 equity shares of Re. 1/- each) to Rs. 13,75,17,622/- (13,75,17,622 equity shares of Re. 1/- each).
Shares of Eris Lifesciences Ltd was last trading in BSE at Rs.612.35 as compared to the previous close of Rs. 612.5. The total number of shares traded during the day was 353 in over 33 trades.
The stock hit an intraday high of Rs. 617.45 and intraday low of 610. The net turnover during the day was Rs. 216769.